ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 2177 • ACR Convergence 2022

    Familial Clustering of Systemic Sclerosis, Autoimmunity, and Cancer History

    Mariana Bombini1, Nailú Sinicato1, Jacqueline Paredes2, Theresa Wampler Muskardin2, Tiago Nardi Amaral1, Ana Paula Del Rio1, Joao Marques Neto3, Timothy Niewold2 and Simone Appenzeller4, 1State University of Campinas, Campinas, São Paulo, Brazil, 2Hospital for Special Surgery, New York, NY, 3State University of Campinas, São Paulo, Brazil, 4Unicamp, Campinas, São Paulo, Brazil

    Background/Purpose: Systemic sclerosis (SSc) is a complex disease characterized by chronic inflammation, fibrosis, and vasculopathy. Genetic factors contribute to pathogenesis, but because it is a…
  • Abstract Number: 0415 • ACR Convergence 2022

    The Association of Early TNF Inhibitor Use with Incident Cardiovascular Events in Ankylosing Spondylitis

    Jean Liew1, Timothy Treu2, yojin Park2, Jacqueline Ferguson3, Morgan Rosser2, yuk-Lam Ho2, Susan Heckbert4, Lianne Gensler5, Katherine Liao6 and Maureen Dubreuil7, 1Boston University School of Medicine, Boston, MA, 2VA Boston Healthcare System, Boston, MA, 3Stanford, Palo Alto, CA, 4University of Washington, Seattle, WA, 5Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, CA, 6Brigham and Women's Hospital, Boston, MA, 7Department of Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: The increased cardiovascular (CV) disease burden in ankylosing spondylitis (AS) is established. Whether tumor necrosis factor inhibitor (TNFi) treatment, particularly when started early in…
  • Abstract Number: 0705 • ACR Convergence 2022

    Severity of SARS-CoV-2 Omicron Breakthrough Infections in Patients with Rheumatic Immune-mediated Inflammatory Diseases and Healthy Controls: Data from a Prospective Cohort Study

    Laura Boekel1, Yaëlle Besten1, Femke Hooijberg1, Rosa Wartena1, Maurice Steenhuis2, Erik Vogelzang3, Maureen Leeuw1, Sadaf Atiqi1, Sander Tas4, Willem Lems5, Marieke van Ham2, Filip Eftimov3, Eileen Stalman3, Luuk Wieske3, Taco Kuijpers3, Alexandre Voskuyl6, Ronald van Vollenhoven7, Martijn Gerritsen1, Charlotte Krieckaert1, Theo Rispens2, Maarten Boers8, Michael Nurmohamed9 and Gertjan Wolbink1, 1Amsterdam Rheumatology and immunology Center, location Reade, Amsterdam, Netherlands, 2Sanquin Research, Amsterdam, Netherlands, 3Amsterdam UMC, location AMC, Amsterdam, Netherlands, 4Amsterdam Rheumatology and immunology Center, location AMC, Amsterdam, Netherlands, 5Amsterdam Rheumatology and immunology Center, location VUMC, Amsterdam, Netherlands, 6Amsterdam UMC, Amsterdam, Netherlands, 7Amsterdam University Medical Centers, Amsterdam, Netherlands, 8Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 9Amsterdam University Medical Center, Kortenhoef, Netherlands

    Background/Purpose: The Omicron (B.1.1.529) variant of SARS-CoV-2 is associated with substantially lower hospitalization rates compared with previous variants of SARS-CoV-2 (i.e., Wildtype, Alpha [B.1.1.7] and…
  • Abstract Number: 0861 • ACR Convergence 2022

    Incidence of Juvenile Idiopathic Arthritis During the COVID-19 Pandemic: An Analysis of National United States Administrative Claims Data

    Daniel Horton1, Amanda Neikirk2, Yiling Yang2, Cecilia Huang3, Stephen Crystal4, amy davidow5, Kevin Haynes6, Tobias Gerhard7, Carlos Rose8, Brian Strom9 and Lauren Parlett2, 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 2HealthCore, Wilmington, DE, 3Rutgers Center for Pharmacoepidemiology and Treatment Science, New Brunswick, NJ, 4Rutgers Center for Health Services Research, New Brunswick, NJ, 5New York University, New York, NY, 6Johnson & Johnson, Titusville, NJ, 7Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, 8Nemours, Chadds Ford, PA, 9Rutgers Biomedical and Health Sciences, Newark, NJ

    Background/Purpose: Limited information exists on how rates of diagnosis of rheumatic diseases have changed during the COVID-19 pandemic. We compared rates of JIA diagnosis before…
  • Abstract Number: 1199 • ACR Convergence 2022

    Validation of New Medication User Definitions in Single-Specialty EHR Data

    Jeffrey Curtis1, Yujie Su2, Michael george3, Cassie Clinton2, Patrick Stewart4, Tim Buekelman5 and Fenglong Xie2, 1Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3UPENN, Philadelphia, PA, 4Bendcare, Boca Raton, FL, 5FASTER, Hoover, AL

    Background/Purpose: New user designs are standard in many pharmacoepidemiology studies, but a first prescription appearance in electronic health record (EHR) data may not always represent…
  • Abstract Number: 1441 • ACR Convergence 2022

    Prevalence of Secondary Connective Tissue Diseases and Autoantibodies Among Racial and Ethnic Groups in Systemic Lupus Erythematosus Patients in the Manhattan Lupus Surveillance Program

    Brendan Denvir1, Philip Carlucci2, Jill Buyon3, H Michael Belmont4, Kelly Corbitt1, Sara Sahl5, Jane Salmon6, Anca Askanase7, Joan Bathon7, Laura Geraldino-Pardilla8, Yousaf Ali9, Ellen M. Ginzler10, Chaim Putterman11, Caroline Gordon12, Hilary Parton13 and Peter Izmirly3, 1New York University, New York, NY, 2New York University School of Medicine, New York, NY, 3NYU Grossman School of Medicine, New York, NY, 4NYU School of Medicine, New York, NY, 5Harbor-University of California Medical Center, Los Angeles, CA, 6Hospital for Special Surgery, New York, NY, 7Columbia University Medical Center, New York, NY, 8Columbia University, New York, NY, 9Icahn School of Medicine at Mount Sinai, New York, NY, 10SUNY Downstate Health Sciences University, Department of Medicine, Brooklyn, NY, 11Albert Einstein College of Medicine, Bronx, NY, 12Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 13New York City Department of Health and Mental Hygiene, New York, NY

    Background/Purpose: Epidemiologic data of secondary connective tissue disease and autoantibody profiles among patients with systemic lupus erythematosus (SLE) remains limited for racial/ethnic populations in the…
  • Abstract Number: 1643 • ACR Convergence 2022

    Use of Oral Analgesics and Risk of Comorbidities in Osteoarthritis: Findings from Primary Care Settings in the UK

    Subhashisa Swain1, Carol Coupland2, Anne Kamps3, Jos Runhaar4, Andrea Dell ‘Isola5, Aleksandra Turkiewicz5, Danielle E Robinson1, Victoria Y Strauss1, Christian Mallen6, Chang-Fu Kuo7, Aliya Sarmanova8, Daniel Prieto Alhambra1, Martin Englund5, Sita Bierma-Zeinstra3, Michael Doherty2 and Weiya Zhang2, 1University of Oxford, Oxford, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3Erasmus University Medical Centre, Rotterdam, Netherlands, 4Erasmus Medical Center, Rotterdam, Netherlands, 5Lund University, Lund, Sweden, 6Keele University, Keele, United Kingdom, 7Chang Gung Memorial Hospital, Taoyuan, Taiwan, 8University of Bristol, Bristol, United Kingdom

    Background/Purpose: People with osteoarthritis (OA) often have multiple other conditions (comorbidities).Role of different oral analgesics on the development of comorbidities in people with OA have…
  • Abstract Number: 1819 • ACR Convergence 2022

    Calcium Pyrophosphate Deposition Disease Is Associated with an Increased Prevalence of Nephrolithiasis

    Alison Fernandes1, Yiran Jiang2, Katherine Sherman3, Ikechukwu Mbonu2, Rebecca Weiner2 and Ann Rosenthal2, 1Medical College of Wisconsin, Oconomowoc, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3Zablocki VA Medical Center, Milwaukee, WI

    Background/Purpose: Calcium pyrophosphate deposition disease (CPDD) is a crystal arthropathy caused by calcium pyrophosphate (CPP) crystals. Individuals with CPDD also have increased risks for other…
  • Abstract Number: 2192 • ACR Convergence 2022

    Serious Infections in Offspring Exposed During Late Pregnancy to Tumour Necrosis Factor Inhibitors with High versus Low Placental Transfer Ability

    Leah K. Flatman1, Yvan St. Pierre2, Isabelle Malhamé3, Olga Basso1, Anick Berard4, Sasha Bernatsky2 and Evelyne Vinet3, 1McGill University, Montréal, QC, Canada, 2Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 3McGill University Health Centre, Montréal, QC, Canada, 4University of Montreal, Montréal, QC, Canada

    Background/Purpose: During pregnancy, best practice guidelines suggest discontinuing tumour necrosis factor inhibitors (TNFi) with high placental transfer before or during the third trimester if the…
  • Abstract Number: 0448 • ACR Convergence 2022

    All-Cause and Cause-Specific Mortality in ANCA-Associated Vasculitis: A Population-based Study

    Anna Wilding1, Maria Weiner2, Jens Rathmann3, Mårten Segelmark1 and Aladdin Mohammad4, 1Nephrology, Department of Clinical Sciences, Lund University, Lund, Sweden, 2Nephrology, Department of Medical and Health Sciences, Linköping, Linköping University, Linköping, Sweden, 3Rheumatology, Department of Clinical Sciences, Lund University, Lund, Skane Lan, Sweden, 4Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden

    Background/Purpose: Despite improvement in treatment and early diagnosis of ANCA-associated Vasculitis (AAV), mortality remains elevated. Early deaths in AAV patients are often attributed to the…
  • Abstract Number: 0706 • ACR Convergence 2022

    Association Between Metabolic Syndrome and Knee Pain over 10-13 Years in Middle-Aged Adults

    Ambrish Singh, Brooklyn Fraser, Alison Venn, Leigh Blizzard, Changhai Ding and Benny Samuel Antony, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

    Background/Purpose: Metabolic syndrome (MetS) is characterised by the clustering of central obesity with metabolic abnormalities. MetS has been suggested as having a role in osteoarthritis…
  • Abstract Number: 0865 • ACR Convergence 2022

    Opioid Use in Youth with Inflammatory Bowel Disease (IBD)-related Arthritis

    Atiye Bilgic Dagci1, Joyce Chang2, Rui Xiao3, Andrew Grossman4 and Pamela Weiss5, 1Children's Hospital of Philadelphia, Bala Cynwyd, PA, 2Boston Children's Hospital, Boston, MA, 3University of Pennsylvania, Philadelphia, PA, 4Children's Hospital of Philadelphia, Philadelphia, 5Children's Hospital of Philadelphia, Glen Mills, PA

    Background/Purpose: Opioid use is common among youth with IBD and associated with increased health care utilization and opioid dependence. Arthritis affects up to 20% of…
  • Abstract Number: 1204 • ACR Convergence 2022

    An Increased Risk of Heart Failure and Heart Failure-Related Death Persists in Rheumatoid Arthritis: A National, Matched Cohort Study from 2000 to 2019

    Tate Johnson1, Yangyuna Yang2, Punyasha Roul3, Windy Alonso2, Joshua Baker4, Brian Sauer5, Grant Cannon6, Ted Mikuls7 and Bryant England2, 1University of Nebraska Medical Center, Elkhorn, NE, 2University of Nebraska Medical Center, Omaha, NE, 3UNMC, Omaha, NE, 4University of Pennsylvania, Philadelphia, PA, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6Retired, Salt Lake City, UT, 7Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA) predisposes patients to heart failure (HF), a leading cause of hospitalization in the US. While improvements in all-cause and cardiovascular (CVD)…
  • Abstract Number: 1449 • ACR Convergence 2022

    Incidence and Risk Factors for Active Tuberculosis in Patients with Systemic Lupus Erythematosus: A Multicenter Prospective Cohort Study

    Lifan Zhang1, xiaoqing zou2, Lantian Xie3, Jianghao Liu3, zhengrong yang4, qifei cao4, Chunlei Li5, Xiaochuan Sun5, Fengchun ZHANG6, Yan Zhao7, Xiaofeng Zeng8 and Xiaoqing Liu1, 1Division of Infectious Diseases, Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Clinical Epidemiology Unit, Peking Union Medical College, International Clinical Epidemiology Network; Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Division of Infectious Diseases, Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 3Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China, 4Division of Infectious Diseases, Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 5Department of Internal medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 6Peking Union Medical College Hospital, Beijing, China, 7Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education, Beijing, China, 8Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China

    Background/Purpose: The burden of tuberculosis (TB) and systemic lupus erythematosus (SLE) in China are both the second largest in the world. Patients with SLE are…
  • Abstract Number: 1662 • ACR Convergence 2022

    Nationwide Distribution of Other Connective Tissue Disease (OCTD) and Systemic Sclerosis (SSc) in Areas of Environmental Concern

    Noelle Kosarek1, Megan Romano2, Robert Simms3, Angeline Andrew4, Erika Moen4, Patricia pioli4 and Michael Whitfield5, 1Dartmouth Geisel School of Medicine, Lebanon, NH, 2Dartmouth College, Lebanon, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Geisel School of Medicine at Dartmouth, Lebanon, NH, 5Dartmouth Geisel School of Medicine, Department of Biomedical Data Science, Lebanon, NH

    Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by fibrosis of the skin and internal organs, vascular abnormalities, and autoantibody formation. The etiology…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology